About the course
Artificial Intelligence in healthcare does not merely optimise processes — it directly influences diagnoses, treatment decisions, patient safety, and institutional trust.
This capstone is the culminating stage of the C-Lab Institute AI Responsibility pathway. Participants step into the role of senior leadership at Meridian Health Network, a nationally recognised hospital group facing a pivotal decision: whether to deploy an AI-powered diagnostic triage system in its emergency departments
The AI system promises:
- 18% improvement in overall diagnostic accuracy
- Faster triage and reduced emergency department wait times
- Improved resource allocation
- Enhanced operational efficiency
However, pilot findings and stakeholder review raise serious concerns:
- Reduced diagnostic accuracy for elderly female patients
- Limited explainability of model outputs
- Complex cross-jurisdictional data sourcing
- Pending national clinical AI guidelines
- Increasing scrutiny from regulators and patient advocates
- Internal pressure from marketing and finance to deploy quickly
The board must determine whether to:
- Deploy system-wide,
- Restrict to advisory-only use,
- Delay pending safeguards and explainability improvements,
- Or suspend deployment until regulatory clarity emerges.
This is not a technical optimisation exercise.
It is a governance decision under clinical, ethical, regulatory, and reputational pressure — where patient lives are directly affected.
What you'll learn
- Risk Analysis: Identify clinical safety threats, demographic biases, and gaps in AI validation studies.
- Regulatory Navigation: Evaluate institutional exposure to regulatory requirements and medical liability.
- Governance Design: Construct oversight committees with clear accountability between clinical and technical staff.
- Operational Safeguards: Implement "human-in-the-loop" protocols and adverse event reporting systems.
- Strategic Decision-Making: Formulate defensible recommendations to continue, restrict, or pause AI deployment.
- Compliance Roadmapping: Develop 12-month monitoring plans to ensure long-term AI transparency and safety.
Requirements
- Pathway Completion: You must have completed the foundational courses in the C-Lab Institute AI Responsibility pathway prior to enrollment.
- No Technical Background Required: This is a clinical governance and executive leadership course. You do not need coding, data science, or technical engineering skills to succeed.
- Industry Interest: A basic understanding of or strong interest in healthcare administration, clinical risk management, and health data regulations is highly recommended.
- Leadership Mindset: You must be prepared to tackle complex executive-level dilemmas where hospital operations, regulatory compliance, and patient lives are directly affected.
Course content
Capstone Objective
Participants will act as Chair of the AI Risk & Governance Committee and prepare a formal Board Memorandum advising Meridian Health Network on a responsible course of action.
The capstone evaluates the leader’s ability to:
• Identify clinical safety and equity risks
• Assess disparities in system performance
• Evaluate regulatory and legal exposure (HIPAA, GDPR, cross-border data issues)
• Address explainability and transparency limitations
• Design governance safeguards and oversight structures
• Recommend a defensible deployment decision
Award
🏅 300 Responsibility Coins
📜 C-Lab Institute AI Responsibility Capstone Certificate
Primary 3R Dimension: Responsibility (Do)
Progression Path: Leader → Fellow
Enrolment options
AI Responsibility Capstone: Clinical AI Under Regulatory Scrutiny - Healthcare Case Study
Artificial Intelligence in healthcare does not merely optimise processes — it directly influences diagnoses, treatment decisions, patient safety, and institutional trust.
This capstone is the culminating stage of the C-Lab Institute AI Responsibility pathway. Participants step into the role of senior leadership at Meridian Health Network, a nationally recognised hospital group facing a pivotal decision: whether to deploy an AI-powered diagnostic triage system in its emergency departments
The AI system promises:
- 18% improvement in overall diagnostic accuracy
- Faster triage and reduced emergency department wait times
- Improved resource allocation
- Enhanced operational efficiency
However, pilot findings and stakeholder review raise serious concerns:
- Reduced diagnostic accuracy for elderly female patients
- Limited explainability of model outputs
- Complex cross-jurisdictional data sourcing
- Pending national clinical AI guidelines
- Increasing scrutiny from regulators and patient advocates
- Internal pressure from marketing and finance to deploy quickly
The board must determine whether to:
- Deploy system-wide,
- Restrict to advisory-only use,
- Delay pending safeguards and explainability improvements,
- Or suspend deployment until regulatory clarity emerges.
This is not a technical optimisation exercise.
It is a governance decision under clinical, ethical, regulatory, and reputational pressure — where patient lives are directly affected.
- Enrolled students: 80
